We suggest that the promoting effect of SLC2A1 on CRC may be associated to m6A modification, and SLC2A1 can impact the CRC methylation level through its correlation with IGF2BP3 and finally impact the development and prognosis of CRC. The gene discussed is IGF2BP3; the disease is colorectal carcinoma.